b'Appendices Appendix 3For positions that exceeded $100,000 in the yearAs of March 31, 2019, Genome Canada has $31.0 ended March 31, 2019, the following are the annualmillion in investments, at market value. These in-salary ranges: vestments are administered in accordance with the Boards approved investment policy and inPresident and CEO $275,000 to $340,000 accordance with the terms and conditions of theVice-Presidents $138,786 to $208,180 contribution agreement with the federal govern- Directors (Band 4) $107,850 to $161,775 ment. The investment policy remained unchangedDirectors (Band 3)$83,809 to $121,713 this past fiscal year. Annual Activity(in millions of dollars)200180160140120100 153.6124.6 120.380 95.1103.66040 59.9 55.4 63.2 62.045.8200 5.8 7.2 6.8 6.4 6.12014-15 2015-16 2016-17 2017-18 2018-19 Genome Canada operating Genome Canada Project co-funding expendituresproject expenditures receivedACKNOWLEDGEMENT We wish to thank the Government of Canada for its leadershipin genomics and continued support of Genome Canada.'